The endocannabinoid system is influenced by compounds found the Cannabis genus of plants and involves two compounds: cannabidiol (CBD) and tetrahydrocannabinol (THC). Federal and state regulation is changing, so the medicinal and recreatoinal use of cannabis-related prodcuts continues to increase. Although not life-threatening, some patients may experience Cannabis Hyperemesis Syndrome. Fortunately, a narrative review outlines the causes and treatment to help get out the weeds of treatment.

Reference: Perisetti A, Gajendran M, Dasari C, et al. Cannabis hyperemesis syndrome: an update on the pathophysiology and management. Annals of Gastroenterology (2020) 33, 1-8. http://www.annalsgastro.gr/files/journals/1/earlyview/2020/ev-09-2020-01-AG_5230-0528.pdf 

CPE details for GameChangers Podcast March 2021

Learning Objective: Describe the potential mechanisms and treatment options for Cannabis Hyperemesis Syndrome.

0107-0000-21-097-H01-P

0.25 CEU/2.5 Hrs (Knowledge)

Initial Release Date: 03/02/21

Expiration Date: 03/02/24

Additional CPE information is located at https://www.ceimpact.com/podcast 

See omnystudio.com/listener for privacy information.